je.st
news
Tag: treatment
New biotech company will develop lupus treatment from Buck Institute
2014-08-20 02:22:18| Biotech - Topix.net
A new company, Mount Tam Biotechnologies , will develop a potential lupus treatment and other compounds under an exclusive license with the Buck Institute for Research on Aging in Novato, the organizations said Monday.
Tags: company
treatment
develop
institute
Oncothyreon cancer drug test in Japan shows 'no treatment effect,' stock falls
2014-08-19 17:02:15| Biotech - Topix.net
Bellevue biotech Oncothyreon Inc. said a test of its lung cancer drug in Japan "did not meet its primary endpoint of an improvement in overall survival, and no treatment effect was seen."
Sound Global Obtained Both Water And Waste Water Treatment Projects In Sichuan Province
2014-08-18 13:56:45| chemicalonline News Articles
Hong Kong - Sound Global Ltd. ("Sound Global", or the "Company";) is pleased to announce that the company has entered into a contract to acquire Bazhong Best Environmental Investment Limited, with which Sound Global have obtained two projects of the acquiree in Enyang District, Bazhong City, namely the Phase I Urban Sewage Treatment Plant Project and the Phase I Urban Water Supply Project
Tags: water
global
sound
obtained
Durham's BioCryst gets $4M to advance experimental Ebola treatment
2014-08-14 14:19:49| Biotech - Topix.net
Additional funding could help BioCryst Pharmaceuticals speed up testing for a drug that may be a possible treatment option for the Ebola virus.
Tags: treatment
advance
experimental
ebola
FDA Approves BELSOMRA (suvorexant) for the Treatment of Insomnia
2014-08-13 22:49:00| Merck.com - Product News
Dateline City: WHITEHOUSE STATION, N.J. BELSOMRA expected to be available in late 2014 or early 2015 WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved BELSOMRA (suvorexant) for adults with insomnia who have difficulty falling asleep and/or staying asleep. BELSOMRA (pronounced bell-SOM-rah) is a highly selective antagonist for orexin receptors. Orexin is a neurotransmitter found in a specific part of the brain that can help keep a person awake. Language: English Contact: MerckMedia Contacts:Pam Eisele, 267-305-3558Megan Wilkinson, 267-305-6463orInvestor Contacts:Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: treatment
fda
approves
insomnia
Sites : [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] next »